Windlas Biotech Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026.
WINDLAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Windlas Biotech has submitted a certificate from its Registrar and Share Transfer Agent, MUFG Intime India Private Limited, under SEBI's Regulation 74(5) for the quarter ended March 31, 2026. The certificate confirms that no dematerialization requests were received during the quarter. The Registrar also noted that the company does not hold any physical shares, meaning all shares are already in demat form. This is a routine quarterly compliance filing with no operational or financial impact.
No impact on shareholders or stock price — this is a standard regulatory compliance disclosure indicating that all shares remain fully dematerialized with no conversion activity during the quarter.